慢性肝病患者出院后过渡期护理的试验 (TLC)
慢性肝病患者出院后过渡期护理的随机试验
Patients with complications of advanced liver disease often have difficulties after hospital discharge that result in early hospital readmission. Poor outcomes for these patients during this transitional time could be improved through the use of innovative transitional care models. This proposal aims to examine the effect of a transitional care model, The Transitional Liver Clinic (TLC), in reducing hospital re-admissions, improving quality of life, and improving patient experience.
研究概览
详细说明
This study is a stepped-wedge randomized trial of 1,000 patients with advanced liver disease at four high-volume centers over 45 months (250 participants/site; <6 participants/site/month) to evaluate the efficacy of the Transitional Liver Clinic (TLC) compared to control.
In the stepped-wedge design, all sites provide usual care (control) during the initial 9-month enrollment interval. At each subsequent 9-month interval, one site is randomized via a computer-generated randomization scheme to crossover to implement the TLC, which will continue through the final interval where all sites will have implemented the TLC.
All sites enroll for the entire 45 months and thus contribute patients to both the control and TLC groups. There are an equal number of TLC and control intervals; thus approximately 500 patients will be in each group. Participant follow-up will occur by telephone at 30 and 90 days after discharge.
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名：Jake McCarty, BS
- 电话号码：317-278-6305
- 邮箱：jacmccar@iu.edu
研究联系人备份
- 姓名：Regina Weber, BS
- 电话号码：317-278-3584
- 邮箱：reginaw@iu.edu
学习地点
-
-
Illinois
-
Chicago、Illinois、美国、60637
- 招聘中
- University of Chicago
-
接触：
- Michael Charleton, MD
- 电话号码：773-702-1234
- 邮箱：mcharlton@medicine.bsd.uchicago.edu
-
-
Indiana
-
Indianapolis、Indiana、美国、46202
- 招聘中
- Indiana University Division of Gastroenterolgy and Hepatology
-
接触：
- Regina Weber, BS, RRT
- 电话号码：317-278-3584
- 邮箱：reginaw@iu.edu
-
接触：
- Eric Orman, MD
- 电话号码：317-278-1630
- 邮箱：esorman@iu.edu
-
首席研究员：
- Eric Orman, MD
-
-
Michigan
-
Ann Arbor、Michigan、美国、48109
- 招聘中
- University of Michigan
-
接触：
- Elliott Tapper, MD
- 电话号码：734- 936-9250
- 邮箱：etapper@umich.edu
-
-
Pennsylvania
-
Philadelphia、Pennsylvania、美国、19141
- 招聘中
- Albert Einstein Healthcare Network
-
接触：
- Victor Navarro, MD
- 电话号码：215-456-8242
- 邮箱：navarrov@einstein.edu
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
-
Male or female age ≥18
-
Diagnosis of advanced liver disease, defined as either (must meet either a or b)
-
cirrhosis based on (either i or ii):
- biopsy
- characteristic clinical, laboratory, and imaging findings
-
acute alcoholic hepatitis, defined by NIAAA Alcoholic Hepatitis Consortia, as
- onset of jaundice (serum bilirubin >3.0 mg/dL) in prior 8 weeks
- consumption of >40 (female) or 60 (male) g alcohol/day for ≥6 months, with <60 days abstinence before jaundice onset,
- AST>50 IU/L, AST/ALT>1.5, and both values <400 IU/L
- liver biopsy confirmation in patients with confounding factors
-
-
Has at least one of the following complications due to advanced liver disease occurring during hospitalization:
- ascites requiring diuretics or paracentesis
- hepatic encephalopathy requiring lactulose or rifaximin
- gastrointestinal bleeding due to portal hypertension
- jaundice
-
Has planned discharge alive to home or a facility within 72 hours of informed consent
-
Able and willing to provide informed consent
Exclusion Criteria:
- discharge under hospice
- listed for liver transplant with MELD-Na ≥ 35
- unable or unwilling to participate in post-discharge follow-up either in-person or virtually
- unable to speak or understand English and/or Spanish
- low hearing or communicative ability (examiner rated) that would interfere with interventions and outcome assessments
- lack of access to a telephone
- incarcerated
- concurrent enrollment in an interventional research study
学习计划
研究是如何设计的？
设计细节
- 主要用途：治疗
- 分配：随机化
- 介入模型：交叉作业
- 屏蔽：无（打开标签）
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
无干预：Control group
Patients in the usual care arm will receive standard follow-up care from their usual providers based on recommendations made by inpatient providers at the time of discharge from the hospital. |
|
|
有源比较器：Transitional Liver Clinic (TLC)
Enrolled patients discharged during the experimental TLC intervention implementation period will receive a phone call from TLC staff within 2 business days of discharge followed by an in-person or video telehealth clinic visit with a hepatology APP within 14 days of discharge. TLC staff will provide additional care based on individual patient needs during the 30-day transitional period. |
Participants in this intervention receive additional attention from their Hepatology providers in terms of an additional call/telemedicine visit and more specific/additional attention from their Hepatology APP (advanced practice provider) based on individual patient needs |
研究衡量的是什么？
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
30-day hospital readmissions for patients hospitalized with complications of advanced liver disease
大体时间：30 days after discharge of initial hospitalization at which the participant was enrolled in the study.
|
The primary outcome, 30-day hospital readmission, is publicly reported by CMS, and is the benchmark measure in the Hospital Readmissions Reduction Program. It is therefore the most appropriate primary outcome. |
30 days after discharge of initial hospitalization at which the participant was enrolled in the study.
|
|
Quality of life for patients hospitalized with complications of advanced liver disease via Promis 29+2 survey
大体时间：30 days after discharge of initial hospitalization at which the participant was enrolled in the study.
|
This measure includes 4 items in each of 7 health domains (physical function, anxiety, depression, fatigue, sleep disturbance, ability to participate in social roles and activities, and pain interference) as well as a single item assessing pain intensity. Each domain is scored using a T-score metric in which 50 corresponds to the average for the US population with a standard deviation of 10, and a higher T-score represents more of the concept being measured. For example, higher fatigue scores indicate more fatigue (worse quality of life), while higher physical function scores represent better physical function (better quality of life). |
30 days after discharge of initial hospitalization at which the participant was enrolled in the study.
|
|
Quality of life for patients hospitalized with complications of advanced liver disease via Promis 29+2 survey
大体时间：90 days after discharge of initial hospitalization at which the participant was enrolled in the study
|
This measure includes 4 items in each of 7 health domains (physical function, anxiety, depression, fatigue, sleep disturbance, ability to participate in social roles and activities, and pain interference) as well as a single item assessing pain intensity. Each domain is scored using a T-score metric in which 50 corresponds to the average for the US population with a standard deviation of 10, and a higher T-score represents more of the concept being measured. For example, higher fatigue scores indicate more fatigue (worse quality of life), while higher physical function scores represent better physical function (better quality of life). |
90 days after discharge of initial hospitalization at which the participant was enrolled in the study
|
|
Patient satisfaction for patients hospitalized with complications of advanced liver disease via the PSQ 18 questionnaire
大体时间：30 days after discharge of initial hospitalization at which the participant was enrolled in the study
|
The PSQ-18 consists of 18 items examining 7 dimensions of satisfaction with medical care: general satisfaction, technical quality, interpersonal manner, communication, financial aspects, time spent with doctor, and accessibility and convenience. Each item is scored with a 1 to 5 Likert scale and the individual item scores are averaged, with higher scores reflecting higher satisfaction. |
30 days after discharge of initial hospitalization at which the participant was enrolled in the study
|
|
Patient satisfaction for patients hospitalized with complications of advanced liver disease via the PSQ 18 questionnaire
大体时间：90 days after discharge of initial hospitalization at which the participant was enrolled in the study
|
The PSQ-18 consists of 18 items examining 7 dimensions of satisfaction with medical care: general satisfaction, technical quality, interpersonal manner, communication, financial aspects, time spent with doctor, and accessibility and convenience. Each item is scored with a 1 to 5 Likert scale and the individual item scores are averaged, with higher scores reflecting higher satisfaction. |
90 days after discharge of initial hospitalization at which the participant was enrolled in the study
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Number of ER visits
大体时间：30 days after discharge of initial hospitalization at which the participant was enrolled in the study and 90 days after discharge of initial hospitalization at which the participant was enrolled in the study
|
Recognizing the limitations on CMS data, the number of ER visits for each participant will be taken from the medical record and will be measured as a secondary outcome to provide a fuller picture of acute care utilization. |
30 days after discharge of initial hospitalization at which the participant was enrolled in the study and 90 days after discharge of initial hospitalization at which the participant was enrolled in the study
|
|
90 day mortality
大体时间：90 days after discharge of initial hospitalization at which the participant was enrolled in the study.
|
Recognizing the limitations on CMS data, 90 day mortality will be measured as a secondary outcome to provide a fuller picture of acute care utilization. |
90 days after discharge of initial hospitalization at which the participant was enrolled in the study.
|
|
Days alive out of the hospital
大体时间：90 days after discharge of initial hospitalization at which the participant was enrolled in the study.
|
Recognizing the limitations on CMS data, number of days alive out of the hospital will be measured as a secondary outcome to provide a fuller picture of acute care utilization. |
90 days after discharge of initial hospitalization at which the participant was enrolled in the study.
|
|
Hospital readmissions
大体时间：30 days after discharge of initial hospitalization at which the participant was enrolled in the study and 90 days after discharge of initial hospitalization at which the participant was enrolled in the study
|
Participants will self report or data will be obtained from local institutional medical records the number of times, if any, they were admitted to the hospital during their time of participation in this study |
30 days after discharge of initial hospitalization at which the participant was enrolled in the study and 90 days after discharge of initial hospitalization at which the participant was enrolled in the study
|
合作者和调查者
调查人员
- 首席研究员：Eric Orman, MD、Indiana University
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.